Skip to main content
SpringerLink
Log in

Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

A multicenter observational study was performed on 839 adult patients with a chronic myeloproliferative disorder and a platelet count in excess of 600×109/l to compare the updated criteria of the Polycythemia Vera Study Group (PVSG) with the recently published WHO classification. Essential thrombocythemia (ET) was diagnosed in 483 patients according to the PVSG; however, when considering histopathology as a major diagnostic feature of the WHO criteria, (true) ET could be established in only 162 patients. The remaining cases were found to represent either initially prefibrotic (184 patients) or early fibrotic (137 patients) chronic idiopathic myelofibrosis (IMF). On the other hand, both classification systems enabled a clear-cut distinction of patients showing overt IMF and polycythemia vera. Follow-up examinations in 140 patients with ET according to the PVSG criteria included also sequential bone marrow biopsies (interval: 38±30 months). A transition into mild reticulin fibrosis occurred in only 2 of 49 patients with (true) ET in contrast to 45 of 91 patients with initial and early IMF where a progression into overt myelofibrosis was encountered. Survival patterns for ET displayed significant differences because according to the PVSG a 16.5% disease-specific loss of life expectancy was calculable compared to a value of only 8.9% when following the WHO criteria. Contrasting this finding, initial and early IMF mimicking ET was characterized by a reduction of life expectancy ranging between 21.6% and 32.3 %. In conclusion, a more accurate classification of ET is warranted by regarding the WHO criteria that include histopathology as a major feature for diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.

Similar content being viewed by others

References

  1. Murphy S (1999) Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia. Semin Hematol 36:9–13

    CAS  Google Scholar 

  2. Kutti J, Wadenvik H (1996) Diagnostic and differential criteria of essential thrombocythemia and reactive thrombocytosis. Leuk Lymphoma 22 [Suppl 1]:41–45

    Google Scholar 

  3. Michiels JJ, Juvonen E (1997) Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group. Semin Thromb Hemost 23:339–347

    CAS  PubMed  Google Scholar 

  4. Eridani S, Sawyer B, Pearson TC (1987) Patterns of in vitro BFU-E proliferation in different forms of polycythaemia and in thrombocythaemia. Eur J Haematol 38:363–369

    CAS  PubMed  Google Scholar 

  5. Juvonen E, Ikkala E, Oksanen K, Ruutu T (1993) Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: diagnostic value and correlation to complications. Br J Haematol 83:192–197

    Google Scholar 

  6. Florensa L, Besses C, Woessner S, Sole F, Acin P, Pedro C, Sans-Sabrafen J (1995) Endogenous megakaryocyte and erythroid colony formation from blood in essential thrombocythaemia. Leukemia 9:271–273

    CAS  PubMed  Google Scholar 

  7. Westwood NB, Pearson TC (1996) Diagnostic applications of haemopoietic progenitor culture techniques in polycythaemias and thrombocythaemias. Leuk Lymphoma 22 [Suppl 1]:95–103

    Google Scholar 

  8. Yan L, Elkassar N, Gardin C, Briere J (1996) Clonality assays and megakaryocyte culture techniques in essential thrombocythemia. Leuk Lymphoma 22 [Suppl 1]:31–40

    Google Scholar 

  9. Chistolini A, Mazzucconi MG, Ferrari A, la Verde G, Ferrazza G, Dragoni F, Vitale A, Arcieri R, Mandelli F (1990) Essential thrombocythemia: a retrospective study on the clinical course of 100 patients. Haematologica 75:537–540

    CAS  PubMed  Google Scholar 

  10. Van Genderen PJ, Michiels JJ (1993) Primary thrombocythemia: diagnosis, clinical manifestations and management. Ann Hematol 67:57–62

    PubMed  Google Scholar 

  11. Dickstein JI, Vardiman JW (1995) Hematopathologic findings in the myeloproliferative disorders. Semin Oncol 22:355–373

    Google Scholar 

  12. Jantunen R, Juvonen E, Ikkala E, Oksanen K, Anttila P, Hormila P, Jansson SE, Kekomaki R, Ruutu T (1998) Essential thrombocythemia at diagnosis: causes of diagnostic evaluation and presence of positive diagnostic findings. Ann Hematol 77:101–106

    Article  CAS  PubMed  Google Scholar 

  13. Buhr T, Georgii A, Schuppan O, Amor A, Kaloutsi V (1992) Histologic findings in bone marrow biopsies of patients with thrombocythemic cell counts. Ann Hematol 64:286–291

    CAS  PubMed  Google Scholar 

  14. Dickstein JI, Vardiman JW (1993) Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes. Am J Clin Pathol 99:513–525

    CAS  PubMed  Google Scholar 

  15. Georgii A, Buesche G, Kreft A (1998) The histopathology of chronic myeloproliferative diseases. Baillieres Clin Haematol 11:721–749

    CAS  PubMed  Google Scholar 

  16. Thiele J, Kvasnicka HM, Diehl V, Fischer R, Michiels J (1999) Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies. Leuk Lymphoma 33:207–218

    CAS  PubMed  Google Scholar 

  17. Pearson TC (1998) Diagnosis and classification of erythrocytoses and thrombocytoses. Baillieres Clin Haematol 11:695–720

    CAS  PubMed  Google Scholar 

  18. Imbert M, Pierre R, Thiele J, Vardiman JW, Brunning RD, Flandrin G (2001) Essential thrombocythaemia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) WHO classification of tumours: tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 39–41

    Google Scholar 

  19. Murphy S, Peterson P, Iland H, Laszlo J (1997) Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Semin Hematol 34:29–39

    CAS  Google Scholar 

  20. Barosi G (1999) Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines. J Clin Oncol 17:2954–2970

    CAS  PubMed  Google Scholar 

  21. Tefferi A (2000) Myelofibrosis with myeloid metaplasia. N Engl J Med 342:1255–1265

    CAS  PubMed  Google Scholar 

  22. Thiele J, Kvasnicka HM, Fischer R (1999) Histochemistry and morphometry on bone marrow biopsies in chronic myeloproliferative disorders—aids to diagnosis and classification. Ann Hematol 78:495–506

    Article  CAS  PubMed  Google Scholar 

  23. Thiele J, Kvasnicka HM, Werden C, Zankovich R, Diehl V, Fischer R (1996) Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact. Leuk Lymphoma 22:303–317

    CAS  PubMed  Google Scholar 

  24. Hakulinen T, Tenkanen L, Abeywickrama K, Paivarinta L (1987) Testing equality of relative survival patterns based on aggregated data. Biometrics 43:313–325

    CAS  PubMed  Google Scholar 

  25. Hakulinen T (1982) Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 38:933–942

    CAS  PubMed  Google Scholar 

  26. Hakama M, Hakulinen T (1977) Estimating the expectation of life in cancer survival studies with incomplete follow-up information. J Chronic Dis 30:585–597

    PubMed  Google Scholar 

  27. Kvasnicka HM, Thiele J, Werden C, Zankovich R, Diehl V, Fischer R (1997) Prognostic factors in idiopathic (primary) osteomyelofibrosis. Cancer 80:708–719

    Article  CAS  PubMed  Google Scholar 

  28. Thiele J, Imbert M, Pierre R, Vardiman JW, Brunning RD, Flandrin G (2001) Chronic idiopathic myelofibrosis. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) WHO classification of tumours: tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 35–38

    Google Scholar 

  29. Thiele J, Kvasnicka HM, Zankovich R, Diehl V (2001) Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis. Ann Hematol 80:160–165

    CAS  PubMed  Google Scholar 

  30. Buhr T, Georgii A, Choritz H (1993) Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification. Pathol Res Pract 189:121–132

    CAS  PubMed  Google Scholar 

  31. Thiele J, Kvasnicka HM, Boeltken B, Zankovich R, Diehl V, Fischer R (1999) Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF)—a clinicopathological study. Leukemia 13:1741–1748

    CAS  PubMed  Google Scholar 

  32. Lengfelder E, Hochhaus A, Kronawitter U, Hoche D, Queisser W, Jahn-Eder M, Burkhardt R, Reiter A, Ansari H, Hehlmann R (1998) Should a platelet limit of 600×109/l be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages. Br J Haematol 100:15–23

    Article  CAS  PubMed  Google Scholar 

  33. Sacchi S, Vinci G, Gugliotta L, Rupoli S, Gargantini L, Martinelli V, Baravelli S, Lazzarino M, Finazzi G (2000) Diagnosis of essential thrombocythemia at platelet counts between 400 and 600×109/L. Gruppo Italiano Malattie Mieloproliferative Croniche (GIMMC). Haematologica 85:492–495

    CAS  PubMed  Google Scholar 

  34. Thiele J, Kvasnicka HM, Zankovich R, Diehl V (2000) Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis. Haematologica 85:1126–1134

    CAS  PubMed  Google Scholar 

  35. Annaloro C, Lambertenghi Deliliers G, Oriani A, Pozzoli E, Lambertenghi Deliliers D, Radaelli F, Faccini P (1999) Prognostic significance of bone marrow biopsy in essential thrombocythemia. Haematologica 84:17–21

    CAS  PubMed  Google Scholar 

  36. Thiele J, Kvasnicka HM, Zankovich R, Diehl V (2002) Early stage idiopathic (primary) myelofibrosis—current issues of diagnostic features. Leuk Lymphoma 43:1035–1041

    CAS  PubMed  Google Scholar 

  37. Murphy S, Iland H, Rosenthal D, Laszlo J (1986) Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Semin Hematol 23:177–182

    CAS  PubMed  Google Scholar 

  38. Bellucci S, Janvier M, Tobelem G, Flandrin G, Charpak Y, Berger R, Boiron M (1986) Essential thrombocythemias. Clinical evolutionary and biological data. Cancer 58:2440–2447

    CAS  PubMed  Google Scholar 

  39. Hehlmann R, Jahn M, Baumann B, Koepcke W (1988) Essential thrombocythemia. Clinical characteristics and course of 61 cases. Cancer 61:2487–2496

    CAS  PubMed  Google Scholar 

  40. Cervantes F, Tassies D, Salgado C, Rovira M, Pereira A, Rozman C (1991) Acute transformation in nonleukemic chronic myeloproliferative disorders: actuarial probability and main characteristics in a series of 218 patients. Acta Haematol 85:124–127

    CAS  PubMed  Google Scholar 

  41. Fenaux P, Simon M, Caulier MT, Lai JL, Goudemand J, Bauters F (1990) Clinical course of essential thrombocythemia in 147 cases. Cancer 66:549–556

    CAS  PubMed  Google Scholar 

  42. Radaelli F, Mazza R, Curioni E, Ciani A, Pomati M, Maiolo AT (2002) Acute megakaryocytic leukemia in essential thrombocythemia: an unusual evolution? Eur J Haematol 69:108-111

    Article  PubMed  Google Scholar 

  43. Cervantes F, Alvarez-Larran A, Talarn C, Gomez M, Montserrat E (2002) Myelofibrosis with myeloid metaplasia following essential thrombocythaemia: actuarial probability, presenting characteristics and evolution in a series of 195 patients. Br J Haematol 118:786-790.

    Article  PubMed  Google Scholar 

  44. Emilia G, Sacchi S, Temperani P, Longo R, Vecchi A (1993) Progression of essential thrombocythemia to blastic crisis via idiopathic myelofibrosis. Leuk Lymphoma 9:423–426

    CAS  PubMed  Google Scholar 

  45. Georgii A, Buhr T, Buesche G, Kreft A, Choritz H (1996) Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies. Leuk Lymphoma 22 [Suppl 1]:15–29

    Google Scholar 

  46. Buhr T, Busche G, Choritz H, Langer F, Kreipe H (2003) Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens. Am J Clin Pathol 119:152-158

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors are greatly indebted to Mrs. B. Rosenbach, Mrs. A. Secgin, and Mr. G. Simons for their excellent technical assistance. Supported by a grant from the Dr. M. Scheel Foundation for Cancer Research (70–2134-Th1) and the F. and M.S. Moritz Foundation (2.1/01).

Author information

Authors and Affiliations

  1. Institute of Pathology, University of Cologne, Joseph-Stelzmannstr.9, 50924 , Cologne, Germany

    J. Thiele & H. M. Kvasnicka

Authors
  1. J. Thiele
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. M. Kvasnicka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Thiele.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thiele, J., Kvasnicka, H.M. Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients. Ann Hematol 82, 148–152 (2003). https://doi.org/10.1007/s00277-002-0604-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-002-0604-y

Keywords

Search

Navigation